 | You can helpexpand this article with text translated fromthe corresponding article in German. (June 2025)Click [show] for important translation instructions.
|
Lars Lindemann | |
|---|---|
 | |
| Member of theBundestag | |
| In office 2021–2024 | |
| Personal details | |
| Born | (1971-05-09)9 May 1971 (age 54) |
| Political party | FDP |
| Alma mater | University of Giessen |
Lars Lindemann (born 9 May 1971) is a German lawyer and politician of theFree Democratic Party who served as a member of theBundestag from 2009 to 2013 and again from 2021 to 2024.[1][2]
Lindemann was born in 1971 in theEast German town of Herzberg.
From 2013 to 2021, he served as chief executive of the Spitzenverband Fachärzte Deutschlands (German Specialist Doctors' Association). Since November 2024, Lindemann has been the chief lobbyist for the pharmaceutical division of Bayer AG.[3][4]
From 2009 to 2013, Lindemann was a member of the Bundestag, representing theBerlin-Tempelhof-Schöneberg district. During that time, he served on the Health Committee.
In 2017, Lindemann was one of the candidates to become chair of theFederal Joint Committee (GBA).[5]
Lindemann became a member of the Bundestag again in the2021 elections.[6] He joined the Health Committee again. In addition to his committee assignments, Lindemann was part of the Parliamentary Friendship Group for Relations with Malta and Cyprus.[6]
In May 2013, Lindemann received criticism from his own FDP youth organization (Young Liberals), which accused him of lobbying. Lindemann announced only one week after his election to second place on the list for the2013 German federal election that he would accept the profession of chief executive of theSpitzenverbandes Fachärzte Deutschlands (National Association of Specialists in Germany). He also worked in a law firm that "specializes in clients from the medical technology and healthcare industries". The JuLis saw this as a conflict of interest with Lindemann's membership in the health committee of the Bundestag.[7]
